Study: Statins may protect hep C patients from liver cancer

03/22/2013 | Reuters

The use of cholesterol-lowering statin drugs among patients with chronic hepatitis C was associated with a decreased risk of liver cancer, according to a study of around 261,000 patients in Taiwan. The reductions were modest, but the findings could address possible concerns about prescribing statins to patients with liver disease, a U.S. researcher commented. The study appeared in the Journal of Clinical Oncology.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations